USP with new Chapter on Supplier Qualification and Guidance for associated Risk Assessments
Recommendation

Tuesday, 24 February 2026 13.00 - 16.30 h
Compliant and Successful Self-Inspections and Internal Audits
As indicated earlier this year, the U.S. Pharmacopeia USP intends to publish a new informational chapter on Supplier Qualification. It was proposed by the General Chapters-Packaging and Distribution Expert Committee. The chapter will get the number <1083>, the former number of the proposed chapter on Good Distribution Practice GDP, which was dismissed.
The aim is to "discuss the importance of supplier qualification and the application of a quality risk-based approach to select, assess, approve, and monitor suppliers of materials and services". Core of the proposal is a six-step process:
- Preparation
- Identification and selection
- Evaluation and acceptance
- Performance monitoring
- Disqualification
- Conditional approval of an existing supplier
For each of these steps, expectations and the rationale of tasks are provided. It is also pointed out that quality risk-based approaches should be used and implemented throughout the process steps. A separate table lists examples of various items that can be considered as part of such a risk assessment. Even though the USP has no direct force of law, certainly not in Europe, interesting pointers for use in risk-based supplier qualification programmes can be found here.
The draft can be viewed in the Pharmacopeial Forum. (Please note: a one-time registration is required to access the Pharmacopeial Forum.)
![]() | Live Online Training: Efficient Supplier Qualification 30/31 March 2022 |
Related GMP News
27.01.2026New Ph. Eur. Publication Schedule
21.01.2026EU Pharma Package: EMA with single Point of Information
14.01.2026European QP Association Developments September through December 2025
14.01.2026Could a change of ownership be relevant to GMP?
07.01.2026Is QP Certification required when Products do not enter EU Territory?
17.12.2025EU Reaches Landmark on Reform of Pharmaceutical Legislation


